Posted this in a different section but feel it should be here. Informal case study: A private school here in Houston opened back up 9-10 days ago for childcare and other lesser services. So... you're talking reduced kids, reduced staff and reduced time onsite. This school, according to people on the inside, was genuinely operating under extreme caution. From all accounts, they did everything right. required masks at all times for staff (with true buy-in, not just "saying the right things") temperature checks for staff, students AND EVEN parents - daily (again, legitimate buy-in and execution) many hands-on tasks, like paperwork, migrated to digital social distancing for kids & staff (designated workspaces for kids) multiple deep cleanings per day This school shut down today or yesterday due to a positive case.
It’s like everything we hear from them is “I can’t explain” when the rest of us could see it for miles and miles. All we need to hear them say is they promise not to get fooled again, but if they’re not up to the task it may be time to look for a substitute.
Im telling you, there's way more asymptomatic cases than they claim. All this bullshit that it's rare is false
Just looking more in depth at the Texas data. https://dshs.texas.gov/coronavirus/additionaldata/ The hospitalizations seem to primarily be coming from Houston and Galveston. Overall hospitalizations are up 527 from 1626 to 2153. Over the past month here is how things look Houston +244 Dallas/Ft Worth +118 Galveston +90 San Antonio +69 Austin +43 And the decliners Amarillo -78 Lubbock -10 Victoria -7 Midland/Odessa -7 Laredo -6
Just passing along some information..... My employer mentioned to me today that they've gained some intel that leads them to believe we will be shutting down again in the next month or so. They basically told us to postpone any travel plans well into the end of this year, and take care of all work from home. We have been working from home as it is, but we were on the verge of going back to the office. Hopefully this isnt true, but they've been pretty spot on with their assumptions thus far. Ugh I am tired of this crap.
I feel ya man. I think there are co-conspirators that help make this virus possible. The more you research and ask questions the more the evasion. For those already vulnerable, it crushed hopes of living a productive life.
Literally zero chance of this happening. We learned our lesson the first time -- the cure (lockdown) was worse than the disease. And COVID really only means death for people who have one foot in the grave already (elderly age, extreme health problems). Someone under 60 y/o getting COVID is hardly a risk at all. Just need to keep them out of nursing homes, where around 1/2 of all COVID deaths have occurred.
The virus is real and unfortunately spreads like wildfire. Still, we crippled the economy where IMO we should have just allowed it to run its course. Just my thought
Just got back from the HEB at Buffalo Speedway. Feels like we are rapidly approaching “the pandemic is over” territory. Doesn’t seem like the carts are getting sprayed down. (At least not after every use). Maybe 50% customer mask wearing. No shortages (except clorox wipes/sprays). Marked difference from March/April. It’s funny cuse nothing has really changed with regards to the virus.. people are just over it I guess.
This so much. I see people are acting like everything is normal again, people are hooping, no more mask, and it's maddening.
Sweden pretty much let it run the course. Their economy is still crippled (in-line with EU members that did lockdown). Lockdown or not, virus like this changes ppl and private company behaviors
we as in your company or the city? my company pretty much stated there is no normal until there is a vaccine I have been assuming that many of us at my workplace would not be back in the physical office this year, and absolutely very limited travel
I was thinking of setting up a remote underwater facility where I would infect great white sharks with Covid in order to better understand how the virus interacts with the human lungs I surgically inserted into their skin.
[NPR] Five Coronavirus Treatments In Development Right now, there is only one drug shown by rigorous scientific testing to be helpful for treating COVID-19. That drug is the antiviral medication called remdesivir, made by Gilead Sciences. But remdesivir's proven benefits are modest: reducing hospital stays from 15 to 11 days. So there's an urgent need for better therapies. The good news is that there are some on the horizon. Some are being tested now, some will be begin testing soon, and others are in the beginning of the pipeline. Convalescent plasma Researchers are expecting to see a benefit from treating COVID-19 with convalescent plasma. This is plasma taken from patients who have had the disease and recovered. Their plasma contains the antibodies their bodies made to successfully fight off the disease, so the theory goes that giving those antibodies to people currently sick with COVID-19 could help them recover. It's an approach that has been used in the past to treat diseases for which there were no effective medicines, including SARS and Ebola, although results are mixed. There are several efforts underway to expand the use of convalescent plasma for treating COVID-19 patients even before its benefit has been proven. The Mayo Clinic is leading one effort, Michigan State University leads another. A similar approach uses something called hyperimmune globulins. These are concentrated versions of the antibodies contained in the convalescent plasma. In addition to using plasma products for therapies, they might also be used to prevent infection in medical workers and other high-risk individuals. Antivirals Remdesivir is what's known as an antiviral drug. It blocks the ability of the coronavirus to make copies of itself and thereby spread through someone's body. Antiviral drugs that have been used to treat other viral infections including HIV are also being tried for COVID-19, so far without proven success. But a new kind of antiviral drug that appears promising is called EIDD-2801. It was created by scientists at a not-for-profit biotech company owned by Emory University. Studies in animals have shown it can reduce the symptoms of SARS, another disease caused by a coronavirus. Last month, the pharmaceutical giant Merck signed a collaborative agreement with Ridgeback Biotherapeutics to develop EIDD-2801, which has already begun testing in humans in the United Kingdom. One significant advantage EIDD-2801 has over remdesivir is that it can be taken as a pill rather than intravenously. Monoclonal antibodies Monoclonal antibodies are laboratory-made molecules that can mimic the human immune system's antibodies. They can be used to target cancer cells, or other undesirable cells, such as those that have been infected with viruses. They have been used successfully to treat a wide ranger of diseases, from cancer to rheumatoid arthritis. They work by supplementing a person's own immune system with antibodies targeted against a specific invader. In the case of COVID-19, that would be antibodies targeted against specific regions of the coronavirus. From the earliest days on the pandemic, researchers have focused on monoclonal antibodies as a potential treatment. There are dozens of groups working on making versions of monoclonal antibodies. The first to begin studies in humans is one developed by the Canadian biotech company AbCellera and the pharmaceutical company Eli Lilly. A second drug based on monoclonal antibodies begins trials in humans today. The drug is actually a cocktail of two monoclonal antibodies, made by the pharmaceutical company Regeneron. In a forthcoming paper in the journal Science, company scientists show the cocktail approach can reduce the chance the virus will develop resistance to the drug. The new drug will be tested both as a treatment for patients with both mild and severe COVID-19 disease, and as a way to prevent people at high risk of getting infected with the coronavirus from developing the disease. Immune modulators Inflammation is a result of the immune system's own efforts to fight off a disease but if that inflammation runs out of control, it can cause severe damage. In the case of COVID-19, that damage is frequently to the lungs, making it hard for a patient to breathe. There are a variety to drugs already on the market that can be used to tamp down the immune response, and there are existing several drugs being tested on patients with COVID-19. The problem with these drugs is they suppress the immune system, so they may reduce someone's ability to fight off the virus, thereby making the viral infection worse. Clinicians say it will take time to learn when and how much of these drugs to use to be of most help to patients. The future It may be possible to design novel drugs for COVID-19 that are different from anything that currently exists. To that end, the White House has launched a The COVID-19 High Performance Computing Consortium. Part of the idea is to create computer models for how the virus infects cells, and then create ways to block that infection process. It's also possible that computing and artificial intelligence could identify existing drugs that could be repurposed to treat COVID-19. It also could be used to track best practices in the way treatments are used.
My HPD friend just tested positive for covid and he said 10% of the police force has it post-protests. He was wearing a mask and all that for the entire time he was out there too.
